Company / Capital Returned to Shareholders
Thermo Fisher Scientific Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$3.6B
FY2025
5-year range
$1.8B / $4.6B
FY2021-FY2025
Trend
-20.7%
vs FY2024
Sector context
#7 of 108
Health Care
What the data says
Among 108 Health Care companies, Thermo Fisher Scientific is in the top 6% for capital returned to shareholders. Capital Returned to Shareholders has fluctuated over the past 10 years, ranging from $766M in FY2018 to $4.6B in FY2024.
Based on SEC 10-K filings.
$3.6B in FY2025 with a 5-year CAGR of +14.6%. Top quartile in the Health Care sector.
Improved from $2.4B to $3.6B over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +25.6%
- 5-Year CAGR
- +14.6%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 108This company $3.6B Sector average $754.9M
▼
+381.7% above sector average
Key checks
Key Insights
- 5-year CAGR of +14.6%, indicating consistent growth.
- In FY2025, capital returned to shareholders decreased 20.7% year-over-year.
- Ranks #7 out of 108 companies in the Health Care sector.
- Peak capital returned to shareholders was recorded in FY2024.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.6B | -20.7% |
| FY2024 | $4.6B | +91.4% |
| FY2023 | $2.4B | +30.4% |
| FY2022 | $1.8B | +2.2% |
| FY2021 | $1.8B | -2.2% |
| FY2020 | $1.8B | +2.2% |
| FY2019 | $1.8B | +134.6% |
| FY2018 | $766.0M | -22.4% |
| FY2017 | $987.0M | -33.7% |
| FY2016 | $1.5B | +100.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026